{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-23-000093","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.901237+00:00","generated_at":"2026-06-08T15:36:58.614523+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Surgery Partners Q3 revenue up 8.6% to $674M; raises FY Adjusted EBITDA guidance to $436-440M","bullets":["Revenues $674.1M (+8.6% YoY); net loss improved to $4.9M from $25M.","Adjusted EBITDA $105.5M (+9.7% YoY); margin improved to 15.7%.","Same-facility revenues up 14.2% (days adjusted); case volume +2.9%, revenue per case +11.0%.","Full-year 2023 Adjusted EBITDA guidance raised to $436-440M; revenue ~$2.75B.","Free Cash Flow of $63.2M in Q3; cash and revolver availability $781M total."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-23-000093","json":"https://secwatch.observer/filing/0001638833-23-000093.json","markdown":"https://secwatch.observer/filing/0001638833-23-000093.md","text":"https://secwatch.observer/filing/0001638833-23-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/sgry-20231107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T15:36:58.614523+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23cdba40e94e318d80c29806be290461b73e4411","claim":"Surgery Partners, Inc. reported 2023 results: revenue approximately $2.75 billion. Guidance raised.","evidence_excerpt":"The Company raised projected 2023 Adjusted EBITDA to a range of $436 million to $440 million and anticipates revenue at approximately $2.75 billion.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2023"},{"label":"Revenue","value":"approximately $2.75 billion"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"5e33ad483d5675163a5c83caf9b5eb1ec99712d5","claim":"Surgery Partners, Inc. reported year-to-date 2023 results: revenue $2,007.9 million, net income $10.9 million.","evidence_excerpt":"respectively, compared to $25.0 million and $96.2 million, respectively, for the same period last year. Year-to-Date 2023 Results Revenues year-to-date 2023 increased 9.6% to $2,007.9 million from $1,832.2 million for the 2022 period. Days adjusted same-facility revenues for year-to-date 2023 increased 10.6% from the same period last year, with an increase in revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year-to-date 2023"},{"label":"Revenue","value":"$2,007.9 million"},{"label":"Net income","value":"$10.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"be1c65b9a0711f08b2328a29e818378fe1b60447","claim":"Surgery Partners, Inc. reported third quarter ended September 30, 2023 results: revenue $674.1 million, net income $4.9 million.","evidence_excerpt":"Partners\" or the \"Company\"), a leading operator of surgical facilities, today announced financial results for the third quarter ended September 30, 2023. • Revenues were $674.1 million representing 8.6% growth • Days Adjusted Same-facility revenues increased 14.2% • Net loss attributable to Surgery Partners was $4.9 million • Adjusted EBITDA was $105.5 million,","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000093/0001638833-23-000093-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$674.1 million"},{"label":"Net income","value":"$4.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}